Skip to content
2000
image of Effects of the Total Flavonoids from Drynaria on Methyltransferase METTL3 and the Coupling of Osteogenesis and Angiogenesis in a Bone Defect Rat Model

Abstract

Introduction

This study aimed to investigate the effects of the Total Flavonoids from (TFRD) on METTL3-mediated m6A methylation and osteogenic-angiogenic coupling during the repair of large bone defects and to elucidate its role in bone remodeling under the Masquelet technique.

Methods

A large femoral bone defect rat model was established in Sprague Dawley (SD) rats using the Masquelet technique. Postoperatively, a total of 24 rats were randomly divided into four groups, namely the model group (MOD), low-dose group (0.11 g/kg/day), mid-dose group (0.22 g/kg/day), and high-dose group (TFRD) (0.44 g/kg/day). These groups were established using the corresponding TFRD dosages or saline interventions. The neobone tissue quality was assessed using X-rays (Lane-Sandhu score), and the bone volume fraction (BV/TV) and trabecular thickness (Tb.Th) were quantified using micro-computed tomography (micro-CT). The localization and expression of type H vessel markers (CD31, EMCN) and measurement of the total RNA m6A methylation levels in the neobone tissues were performed using Immunohistochemistry (IHC). The osteogenic-angiogenic coupling factors (BMP-2, PDGF-BB, S1P) and m6A methylation regulators (METTL3, IGF2BP2) were analyzed using a western blot and qRT-PCR.

Results

The micro-CT and X-ray techniques revealed that TFRD significantly enhanced the neobone tissue quality, increased the BV/TV, and thickened Tb.Th compared to the MOD group. IHC showed a dose-dependent upregulation of the CD31 and EMCN expression areas and intensity in the neobone tissues, in addition to elevated m6A methylation levels with increasing TFRD doses. The western blot showed that the osteogenic-angiogenic coupling proteins (PDGF-BB, S1P, BMP-2) and m6A regulators (METTL3, IGF2BP2) were upregulated in a dose-dependent manner. Notably, while qRT-PCR indicated that TFRD suppressed PDGF-BB mRNA expression, the protein level was elevated, suggesting potential post-transcriptional regulation. The mRNA levels of BMP-2, S1P, METTL3, and IGF2BP2 were enhanced.

Discussion

This study suggests that TFRD promotes bone regeneration not only by enhancing osteogenic and angiogenic factor expression but also through epitranscriptomic regulation via the METTL3-m6A axis. The discordance between PDGF-BB mRNA and protein levels implies a potential post-transcriptional regulatory mechanism, possibly mediated by m6A modification, which merits further investigation. This study provides novel insights into the pharmacological mechanism of TFRD, positioning it as a promising candidate for adjunctive therapy in bone defect repair.

Conclusion

TFRD facilitated bone regeneration by modulating METTL3-mediated m6A methylation, upregulating osteogenic-angiogenic coupling factors, and stimulating type H vessel formation. These findings support the potential of TFRD as a promising therapeutic agent for bone defect repair. TFRD acted through mechanisms that involve RNA methylation and enhanced the interaction between osteogenesis and angiogenesis. Targeting the epitranscripto-mic regulation of bone-vascular interaction may open new avenues for orthopedic rehabilitation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240436889251110075723
2025-11-14
2026-03-01

  • From This Site

    /content/journals/cmm/10.2174/0115665240436889251110075723
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Mathieu L. Ghabi A. Druel T. Masquelet technique including a multiperforated non-vascularized fibula graft for the reconstruction of massive post-traumatic bone defects in military practice. Eur. J. Trauma Emerg. Surg. 2025 51 1 90 10.1007/s00068‑024‑02722‑5 39891669
    [Google Scholar]
  2. Kanakaris N.K. Rodham P. Giannoudis V.P. Giannoudis P.V. Modern management of severe open fractures of the extremities. J. Bone Joint Surg. Am. 2025 107 5 504 517 10.2106/JBJS.24.00647 39908357
    [Google Scholar]
  3. Roberts W.E. Huja S. Roberts J.A. Bone modeling: Biomechanics, molecular mechanisms, and clinical perspectives. Semin. Orthod. 2004 10 2 123 161 10.1053/j.sodo.2004.01.003
    [Google Scholar]
  4. Liu X. Zhang P. Gu Y. Guo Q. Liu Y. Type H vessels: Functions in bone development and diseases. Front. Cell Dev. Biol. 2023 11 1236545 10.3389/fcell.2023.1236545 38033859
    [Google Scholar]
  5. Xu J. He S. Xia T. Shan Y. Wang L. Targeting type H vessels in bone‐related diseases. J. Cell. Mol. Med. 2024 28 4 e18123 10.1111/jcmm.18123 38353470
    [Google Scholar]
  6. Xiao D. Zhang D. Qu Y. Su X. Methyltransferase‐like 3‐mediated N6‐methyladenosine modification on RNAs: A novel perspective for the pathogenesis and treatment of bone diseases. J. Cell. Mol. Med. 2025 29 5 e70483 10.1111/jcmm.70483 40052548
    [Google Scholar]
  7. Liu X.W. Xu H.W. Yi Y.Y. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms. Biochim. Biophys. Acta Mol. Basis Dis. 2024 1870 7 167273 10.1016/j.bbadis.2024.167273 38844111
    [Google Scholar]
  8. Tian S. Song Y. Guo L. Zhao H. Bai M. Miao M. Epigenetic mechanisms in osteoporosis: Exploring the power of m 6 A RNA modification. J. Cell. Mol. Med. 2025 29 1 e70344 10.1111/jcmm.70344 39779466
    [Google Scholar]
  9. Yang P. Wang H. Meng L. Kou Y. Bu J. Li M. Methylase METTL3 regulates oxidative stress-induced osteoblast apoptosis through Wnt/β-catenin signaling pathway. J. Mol. Histol. 2025 56 2 86 10.1007/s10735‑025‑10358‑x 39928245
    [Google Scholar]
  10. Li X. Peng L. Yang X. N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment. Front. Immunol. 2024 15 1464042 10.3389/fimmu.2024.1464042 39759516
    [Google Scholar]
  11. Xie Z. Luo H. Wang T. METTL3 inhibits BMSC apoptosis and facilitates osteonecrosis repair via an m6A-IGF2BP2-dependent mechanism. Heliyon 2024 10 10 e30195 10.1016/j.heliyon.2024.e30195 38784565
    [Google Scholar]
  12. Zhao Y. Cai X. Sun J. Bi W. Yu Y. Active components and mechanisms of total flavonoids from Rhizoma Drynariae in enhancing cranial bone regeneration: An investigation employing serum pharmacochemistry and network pharmacology approaches. J. Ethnopharmacol. 2024 319 Pt 3 117253 10.1016/j.jep.2023.117253 37778522
    [Google Scholar]
  13. Lin H. Li Z. Xie Z. An anti-infection and biodegradable TFRD-loaded porous scaffold promotes bone regeneration in segmental bone defects: experimental studies. Int. J. Surg. 2024 110 6 3269 3284 10.1097/JS9.0000000000001291 38506734
    [Google Scholar]
  14. Huang X. Li C. Lau Y. Lin Z. OuYang C. Zheng L. The sustained-release agent of total flavonoids of Rhizoma drynariae prepared by nano-mesoporous silica can still promote osteogenesis and angiogenesis in vitro. Sci. Rep. 2025 15 1 5045 10.1038/s41598‑025‑88137‑7 39934173
    [Google Scholar]
  15. Li Q. Wu X. Niu X. Integrated metagenomic and metabolomic analyses of the effects of total flavonoids of Rhizoma Drynariae on reducing ovariectomized-induced osteoporosis by regulating gut microbiota and related metabolites. PLoS One 2025 20 2 e0317832 10.1371/journal.pone.0317832 39951448
    [Google Scholar]
  16. Kaneko Y. Minehara H. Sonobe T. Differences in macrophage expression in induced membranes by fixation method – Masquelet technique using a mouse’s femur critical-sized bone defect model. Injury 2024 55 6 111135 10.1016/j.injury.2023.111135 37925281
    [Google Scholar]
  17. Xie H. Cui Z. Wang L. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med. 2014 20 11 1270 1278 10.1038/nm.3668 25282358
    [Google Scholar]
  18. Frost K. Naylor A.J. McGettrick H.M. The Ying and Yang of Sphingosine-1-Phosphate Signalling within the Bone. Int. J. Mol. Sci. 2023 24 8 6935 10.3390/ijms24086935 37108099
    [Google Scholar]
  19. Hsu L.C. Reddy S.V. Yilmaz Ö. Yu H. Sphingosine-1-phosphate receptor 2 controls podosome components induced by RANKL affecting osteoclastogenesis and bone resorption. Cells 2019 8 1 17 10.3390/cells8010017 30609675
    [Google Scholar]
  20. Zhang Q Li J Wang C Methyladenosine in cell-fate determination of BMSCs: From mechanism to applications. Research (Wash D C) 2024 7 0340 10.34133/research.0340
    [Google Scholar]
  21. Zhou S. Zhang G. Wang K. Yang Z. Tan Y. METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2. Oral Dis. 2024 30 3 1313 1321 10.1111/odi.14526 36705430
    [Google Scholar]
  22. Luo Y. Shi Y. Wu Y. Cao H. METTL3-mediated m6A modification of circSTAT6 modulates miR-188-3p/Beclin1 axis to promote osteogenic differentiation of mesenchymal stem cells. J. Orthop. Surg. Res. 2025 20 1 313 10.1186/s13018‑025‑05720‑4 40134002
    [Google Scholar]
  23. Gu T. Guo R. Fang Y. METTL3-mediated pre-miR-665/DLX3 m6A methylation facilitates the committed differentiation of stem cells from apical papilla. Exp. Mol. Med. 2024 56 6 1426 1438 10.1038/s12276‑024‑01245‑8 38825638
    [Google Scholar]
  24. Wei J. Dong R. Ma Y. Single-cell sequencing reveals that specnuezhenide protects against osteoporosis via activation of METTL3 in LEPR+ BMSCs. Eur. J. Pharmacol. 2024 981 176908 10.1016/j.ejphar.2024.176908 39154827
    [Google Scholar]
  25. Tang H. Chen Z. Zeng L. Accelerating bone healing with METTL3 overexpressed adipose‐derived stem cells in osteoporotic rats. Cell Prolif. 2025 58 9 e70029 10.1111/cpr.70029 40125696
    [Google Scholar]
/content/journals/cmm/10.2174/0115665240436889251110075723
Loading
Effects of the Total Flavonoids from Drynaria on Methyltransferase METTL3 and the Coupling of Osteogenesis and Angiogenesis in a Bone Defect Rat Model
Bentham Science Publishers ; https://doi.org/10.2174/0115665240436889251110075723
/content/journals/cmm/10.2174/0115665240436889251110075723
/content/journals/cmm/10.2174/0115665240436889251110075723
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: total flavonoids from Drynaria ; METTL3 ; bone defect ; osteogenic-angiogenic coupling ; Masquelet technique ; m6A methylation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test